The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

food microbiology and bioremediation. Two studies report the development of genetically engineered, kill-switch-encoding strains of Mycobacterium tuberculosis and Mycobacterium bovis bacillus ...

Currently, the most widely used vaccine against TB is the Bacillus Calmette-Guérin (BCG). Developed in 1921, the vaccine ...

Mammalian hosts coordinate various cell death pathways as part of the immune defense system against pathogens including ...

Indeed, the pathogen seems like ancient history — but as recent developments indicate, tuberculosis isn’t done with us yet.

This important study reveals that disrupting fatty acid metabolism in macrophages significantly restricts the growth of Mycobacterium tuberculosis, showing that impaired lipid processing triggers ...

Australian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine ...

A new study published in Biochemistry sheds light on how bacteria regulate their genes ... how two bacterial species—Escherichia coli and Mycobacterium tuberculosis—use a signaling molecule ...

This study investigates the role of macrophage lipid metabolism in the intracellular growth of Mycobacterium tuberculosis. By using a CRISPR-Cas9 gene-editing approach, the authors knocked out key ...

Over 200 visitors interacted with each other over themes of drug resistant tuberculosis, extra-pulmonary TB and developments ...

Every year, 10 million people contract tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb), and approximately 1.5 million patients succumb to the disease. Treatment ...